Macrophage migration inhibitory factor (MIF): a promising biomarker

Area of Science:

• Immunology
• Genetics
• Biomarker Discovery

Background:

• Macrophage migration inhibitory factor (MIF) is an immunoregulatory cytokine with a known role in immune cell movement.
• Historically recognized for inhibiting immune cell migration, MIF also exhibits chemokine-like functions, promoting cell recruitment.
• MIF is implicated in various inflammatory conditions, including infections, autoimmune diseases, cancer, and metabolic disorders.

Purpose of the Study:

• To review clinical data on Macrophage migration inhibitory factor (MIF).
• To discuss the potential of MIF as a biomarker for diverse disease applications.
• To explore the significance of MIF gene polymorphisms in disease susceptibility and outcome prediction.

Main Methods:

• Review of existing clinical studies and genetic association data related to MIF.
• Analysis of MIF's dual role as an immunoregulatory cytokine and a chemoattractant.
• Examination of functional promoter polymorphisms within the MIF gene.

Main Results:

• Clinical studies support MIF's utility as a biomarker in inflammatory diseases like sepsis, autoimmune disorders, cancer, type 2 diabetes, and obesity.
• Functional polymorphisms in the MIF gene correlate with disease susceptibility and severity.
• MIF's involvement extends beyond immune cell inhibition to active cell recruitment.

Conclusions:

• Macrophage migration inhibitory factor (MIF) is a validated biomarker for numerous inflammatory diseases.
• MIF gene polymorphisms offer potential for predicting individual disease risk and prognosis.
• Further investigation into MIF's clinical applications as a biomarker is warranted.